← back to search

Anil Shanker

National Human Genome Research Institute · US

Area of research

Immunology · Oncology

Research interest

Research interests include Medicine, Bevacizumab, Carboplatin, Internal medicine, and Regimen.

h-index

—

citations

23

works

1

NIH funding

—

primary concept

—

email

✉ Find email ↗

Recent publications

Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508)

Clinical Lung Cancer 2020cited by 23position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 1 papers (2020–2020)Jyoti D. Patel · Northwestern University1 papers (2020–2020)— · 1 papers (2020–2020)Melissa L. Johnson · Cancer Institute (WIA)1 papers (2020–2020)Joan H. Schiller · Virginia Department of Health1 papers (2020–2020)David E. Gerber · Simmons University1 papers (2020–2020)Millie Das · Stanford Medicine1 papers (2020–2020)David P. Carbone · Washington University in St. Louis1 papers (2020–2020)Leora Horn · Vanderbilt University1 papers (2020–2020)Henry Wagner · Pennsylvania State University1 papers (2020–2020)Suresh S. Ramalingam · Emory University1 papers (2020–2020)Maria Teresa P. de Aquino · Cleveland Clinic Lerner College of Medicine1 papers (2020–2020)Ju-Whei Lee · Gilead Sciences (United States)1 papers (2020–2020)— · 1 papers (2020–2020)